Boundless Bio, Inc.
BOLD
$2.83
$0.061.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 107.57% | 13.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 57.23% | 3.38% | |||
| Operating Income | -57.23% | -3.38% | |||
| Income Before Tax | -74.79% | -5.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -74.79% | -5.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -74.79% | -5.20% | |||
| EBIT | -57.23% | -3.38% | |||
| EBITDA | -51.52% | -3.62% | |||
| EPS Basic | -74.48% | -5.16% | |||
| Normalized Basic EPS | -62.50% | -5.17% | |||
| EPS Diluted | -74.48% | -5.16% | |||
| Normalized Diluted EPS | -62.50% | -5.17% | |||
| Average Basic Shares Outstanding | 0.19% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||